Skip Nav

HIV/AIDS Clinical Trials

Recruiting Status Legend

Studies Seeking Participants

Recruiting
Not yet recruiting
Available for expanded access

Studies Not Seeking Participants

Active, not recruiting
Completed
Terminated
Suspended
Withdrawn
Enrolling by invitation
Temporarily not available for expanded access
No longer available for expanded access
Approved for marketing

Clinical Trial Search Results

32 studies were found about rifabutin

Rifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected Adults

Condition: Staphylococcus Aureus; HIV Infections

NCT ID: NCT00869518

Enrolling by invitation

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00640887

Completed

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00651066

Active, not recruiting

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00002080

Completed

The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00001030

Completed

Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults

Condition: HIV Infections

NCT ID: NCT00000877

Completed

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023400

Completed

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023348

Completed

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV

Condition: HIV Infection; Tuberculosis

NCT ID: NCT01601626

Not yet recruiting

The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00001023

Completed

Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00018083

Recruiting

Safety And Efficacy Of Rifabutin In HIV Patients

Condition: Non-tuberculous Mycobacterial Diseases (Including MAC Disease); Tuberculosis; Inhibition of Disseminated Mycobacterium Avium Complex (MAC) Disease Associated With HIV Infections

NCT ID: NCT00810446

Enrolling by invitation

TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023361

Completed

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023413

Completed

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

Condition: Opioid Dependency; HIV Infections

NCT ID: NCT00877591

Completed

A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients

Condition: Mycoses; Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00002122

Completed

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Condition: HIV; Tuberculosis

NCT ID: NCT01663168

Recruiting

A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00002101

Completed

A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00002343

Completed

Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra

Condition: Children With Confirmed HIV Infection; Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose; Successfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment

NCT ID: NCT01259219

Recruiting

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00002267

Completed

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00002032

Completed

Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites

Condition: Bacterial Infections; Mycoses; HIV Infections

NCT ID: NCT00000826

Completed

A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00001995

Completed

Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00001047

Completed

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00004736

Completed(En español)

A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00001058

Completed

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

Condition: HIV; Tuberculosis

NCT ID: NCT00743470

Terminated

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01059422

Recruiting

Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01231542

Completed

Drug Interaction Study

Condition: Antivirals/HIV

NCT ID: NCT00646776

Completed

Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061)

Condition: Healthy Volunteers

NCT ID: NCT00925535

Completed